SEI Medical PCL (BKK:SEI)

SEI Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	473.2	443.98	393.57	320.55	375.73	377.68
Other Revenue	-	-	-	-	2.47	-
Revenue	473.2	443.98	393.57	320.55	378.2	377.68
Revenue Growth (YoY)	13.96%	12.81%	22.78%	-15.24%	0.14%	7.93%
Cost of Revenue	314.47	289.66	277.26	219.11	266.41	247.74
Gross Profit	158.73	154.32	116.31	101.44	111.79	129.94
Selling, General & Admin	92.74	89.11	86.38	78.17	61.84	66.73
Other Operating Expenses	-0.57	-	-	-	25.29	21.71
Operating Expenses	92.17	89.11	86.38	78.17	87.13	88.43
Operating Income	66.56	65.21	29.93	23.27	24.66	41.51
Interest Expense	-2.28	-3.34	-3.29	-2.78	-3.14	-2.98
Interest & Investment Income	2.03	2.31	0.82	0.04	0.01	0.01
Currency Exchange Gain (Loss)	-	-	-	-	-1.42	0.12
Other Non Operating Income (Expenses)	0.05	0.05	0.01	0.28	-	0
EBT Excluding Unusual Items	66.35	64.23	27.48	20.81	20.1	38.67
Gain (Loss) on Sale of Assets	1.07	1.07	0.01	1.77	1.68	0.52
Asset Writedown	-	-	-	-	-0.01	-
Other Unusual Items	-	-	-	-	-	-0.01
Pretax Income	67.42	65.3	27.49	22.59	21.78	39.17
Income Tax Expense	12.45	11.88	5.62	4.72	6.34	10.37
Net Income	54.96	53.42	21.87	17.86	15.44	28.79
Net Income to Common	54.96	53.42	21.87	17.86	15.44	28.79
Net Income Growth	38.76%	144.26%	22.43%	15.73%	-46.39%	25.53%
Shares Outstanding (Basic)	170	134	120	100	12	12
Shares Outstanding (Diluted)	170	134	120	100	12	12
Shares Change (YoY)	39.81%	12.09%	19.48%	735.07%	-	-
EPS (Basic)	0.32	0.40	0.18	0.18	1.29	2.40
EPS (Diluted)	0.32	0.40	0.18	0.18	1.29	2.40
EPS Growth	-0.75%	117.91%	2.47%	-86.14%	-46.39%	-
Free Cash Flow	40.05	39.64	-29.95	34.55	-	-
Free Cash Flow Per Share	0.24	0.29	-0.25	0.34	-	-
Dividend Per Share	0.120	0.120	-	41.670	-	-
Gross Margin	33.54%	34.76%	29.55%	31.65%	29.56%	34.41%
Operating Margin	14.07%	14.69%	7.61%	7.26%	6.52%	10.99%
Profit Margin	11.62%	12.03%	5.56%	5.57%	4.08%	7.62%
Free Cash Flow Margin	8.46%	8.93%	-7.61%	10.78%	-	-
EBITDA	77.85	76.04	41.81	36.58	-	46.39
EBITDA Margin	16.45%	17.13%	10.62%	11.41%	-	12.28%
D&A For EBITDA	11.29	10.82	11.87	13.31	-	4.88
EBIT	66.56	65.21	29.93	23.27	24.66	41.51
EBIT Margin	14.07%	14.69%	7.61%	7.26%	6.52%	10.99%
Effective Tax Rate	18.47%	18.19%	20.43%	20.91%	29.12%	26.49%
Revenue as Reported	473.2	443.98	393.57	320.55	379.9	378.33
Advertising Expenses	-	-	-	-	0.7	1.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.